Cancer BiologybioRxivPreprint
Hematological and Neurological Expressed 1 (HN1): a predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Nicholas W. Bateman, Pang-ning Teng, Erica Hope…·Thomas P. Conrads
This study identifies HN1 as a predictive and pharmacodynamic biomarker of metformin response in endometrioid endometrial cancer, showing it is elevated in responders and decreases after treatment.
DOI 10.1101/602870